Rezultaty - Xiuning Le

Targeting the MET gene: unveiling therapeutic opportunities in immunotherapy within the tumor immune microenvironment of non-small cell lung cancer od Lisha Ye, Wenjing Wang, Huihui Li, Yongling Ji, Xiuning Le, Xiaoling Xu

Dokumenty pełnotekstowe

Antibody-drug conjugates in lung cancer: dawn of a new era? od Niamh Coleman, Timothy A. Yap, John V. Heymach, Funda Meric-Bernstam, Xiuning Le

Dokumenty pełnotekstowe

Progress and challenges of artificial intelligence in lung cancer clinical translation od Erjia Zhu, Amgad Muneer, Jianjun Zhang, Yang Xia, Xiaomeng Li, Caicun Zhou, John V. Heymach, Jia Wu, Xiuning Le

Dokumenty pełnotekstowe

Ensartinib for advanced or metastatic non-small-cell lung cancer with MET exon 14 skipping mutations (EMBRACE): a multi-center, single-arm, phase 2 trialResearch in context od Yang Xia, Panwen Tian, Mo Zhou, Jun Zhao, Yang Jin, Zhiyuan Guo, Xiuzhen Li, Weina Lu, Da Miao, Yuefei Lu, Wanting Xu, Yongchang Zhang, Xiuning Le, Wen Li

Dokumenty pełnotekstowe

Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients od Lingzhi Hong, Sonia Patel, Leylah M. Drusbosky, Yuanyuan Xiong, Rongrong Chen, Ruixuan Geng, Simon Heeke, Monique Nilsson, Jia Wu, John V. Heymach, Yingyi Wang, Jianjun Zhang, Xiuning Le

Dokumenty pełnotekstowe

Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening od Sara Nofal, Jiangong Niu, Paul Resong, Jeff Jin, Kelly W. Merriman, Xiuning Le, Hormuzd Katki, John Heymach, Mara B. Antonoff, Edwin Ostrin, Jia Wu, Jianjun Zhang, Iakovos Toumazis

Dokumenty pełnotekstowe

Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib od Mo Zhou, Yin Zhu, Xuqi Sun, Ying Han, Rui Jin, Panwen Tian, Jun Zhao, Yang Jin, Zhiyuan Guo, Yongchang Zhang, Yiran Meng, Fei Liu, Wen Li, Xiuning Le, Haifeng Shen, Yang Xia

Dokumenty pełnotekstowe

Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood od Yang Xia, Yin Zhu, Sai Zhang, Mo Zhou, Jiaqi Zhou, Guanxin Xu, Baiqin Zhao, Guofei Zhang, Qiyuan Wang, Bin Wang, Zexin Chen, Hongyu Shi, Xiuning Le, Tony Mok, Wei Chen, Junqiang Fan, Weiwei Yin, Wen Li

Dokumenty pełnotekstowe

Targeting MET in NSCLC: An Ever-Expanding Territory od Ying Han, MD, Yinghui Yu, MD, Da Miao, MD, Mo Zhou, MD, Jing Zhao, MD, Zhehua Shao, MD, PhD, Rui Jin, MD, Xiuning Le, MD, PhD, Wen Li, MD, Yang Xia, MD, PhD

Dokumenty pełnotekstowe

The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lu... od Balazs Halmos, Narjust Florez, Sarah Goldberg, Wade Iams, Xiuning Le, Ticiana Leal, Danny Nguyen, Luis E. Raez, Jonathan W. Riess, Joshua Sabari, David Bjork, Nichelle Stigger, Yichuan Xia, Paul Cifuentes, Denise D’Andrea, Farah Shanoon, Andy L. Johnson, Melissa L. Johnson

Dokumenty pełnotekstowe

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson od Jeong Uk Lim, Heather Y. Lin, Lei Kang, Hung Le, Tin-Yun Tang, Stephane Champiat, Ecaterina Elena Dumbrava, Xiuning Le, Aung Naing, Sarina A. Piha-Paul, Jordi Rodon Ahnert, Apostolia Maria Tsimberidou, Timothy A. Yap, Siqing Fu, Funda Meric-Bernstam, David S. Hong

Dokumenty pełnotekstowe

Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features od Hui Li, Hui Li, Xin Hu, Matthew S. Ning, Gregory N. Fuller, John M. Stewart, Jared C. Gilliam, Jia Wu, Jia Wu, Xiuning Le, Ara A. Vaporciyan, J. Jack Lee, Don L. Gibbons, Don L. Gibbons, John V. Heymach, Andrew Futreal, Jianjun Zhang, Jianjun Zhang

Dokumenty pełnotekstowe

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity od Xiuning Le, Jacqulyne P. Robichaux, Monique Nilsson, R. S. K. Vijayan, Ashwin Ravichandran, Jia Wu, Yasir Y. Elamin, Lingzhi Hong, Jun Pei, Jun He, Sonia Patel, Hibiki Udagawa, Sriramvignesh Mani, Chang Woon Jang, Jeffrey M. Clarke, Nishan Tchekmedyian, Jonathan W. Goldman, Mark Socinski, Gajanan Bhat, Sharon Leu, Veronica Bunn, Zhenqiang Su, Sylvie Vincent, John W. Lawson, Jason B. Cross, John V. Heymach

Dokumenty pełnotekstowe

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC od Maliazurina B. Saad, Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Daniel Boiarsky, Shenduo Li, Milena Petranovic, Carol C. Wu, Brett W. Carter, Girish S. Shroff, Tina Cascone, Xiuning Le, Yasir Y. Elamin, Mehmet Altan, Simon Heeke, Ajay Sheshadri, Joe Y. Chang, Percy P. Lee, Zhongxing Liao, Don L. Gibbons, Ara A. Vaporciyan, J. Jack Lee, Ignacio I. Wistuba, Cara Haymaker, Seyedali Mirjalili, David Jaffray, Justin F. Gainor, Yanyan Lou, Alessandro Di Federico, Federica Pecci, Mark Awad, Biagio Ricciuti, John V. Heymach, Natalie I. Vokes, Jianjun Zhang, Jia Wu

Dokumenty pełnotekstowe

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights od Sheeba J. Sujit, Muhammad Aminu, Tatiana V. Karpinets, Pingjun Chen, Maliazurina B. Saad, Morteza Salehjahromi, John D. Boom, Mohamed Qayati, James M. George, Haley Allen, Mara B. Antonoff, Lingzhi Hong, Xin Hu, Simon Heeke, Hai T. Tran, Xiuning Le, Yasir Y. Elamin, Mehmet Altan, Natalie I. Vokes, Ajay Sheshadri, Julie Lin, Jianhua Zhang, Yang Lu, Carmen Behrens, Myrna C. B. Godoy, Carol C. Wu, Joe Y. Chang, Caroline Chung, David A. Jaffray, Ignacio I. Wistuba, J. Jack Lee, Ara A. Vaporciyan, Don L. Gibbons, John Heymach, Jianjun Zhang, Tina Cascone, Jia Wu

Dokumenty pełnotekstowe

Analysis of germline-driven ancestry-associated gene expression in cancers od Nyasha Chambwe, Rosalyn W. Sayaman, Donglei Hu, Scott Huntsman, Anab Kemal, Samantha Caesar-Johnson, Jean C. Zenklusen, Elad Ziv, Rameen Beroukhim, Andrew D. Cherniack, Jian Carrot-Zhang, Ashton C. Berger, Seunghun Han, Matthew Meyerson, Jeffrey S. Damrauer, Katherine A. Hoadley, Ina Felau, John A. Demchok, Michael K.A. Mensah, Roy Tarnuzzer, Zhining Wang, Liming Yang, Theo A. Knijnenburg, A. Gordon Robertson, Christina Yau, Christopher Benz, Kuan-lin Huang, Justin Y. Newberg, Garrett M. Frampton, R. Jay Mashl, Li Ding, Alessandro Romanel, Francesca Demichelis, Wanding Zhou, Peter W. Laird, Hui Shen, Christopher K. Wong, Joshua M. Stuart, Alexander J. Lazar, Xiuning Le, Ninad Oak

Dokumenty pełnotekstowe

Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer od Charles Lu, Mehmet Altan, Apar Pataer, Tina Cascone, Annikka Weissferdt, Jianjun Zhang, Boris Sepesi, Ara A Vaporciyan, Marcelo V Negrao, Hai T Tran, Stephen G Swisher, John V Heymach, Don L Gibbons, Brett W Carter, Jack A Roth, Ferdinandos Skoulidis, Yasir Y Elamin, Xiuning Le, Wayne L Hofstetter, J Jack Lee, Bonnie S Glisson, Myrna C B Godoy, Garrett L Walsh, Jia Wu, Humam Kadara, George R Blumenschein, Heather Y Lin, Nicolas Zhou, William N William, Cheuk H Leung, Frank V Fossella, Anne S Tsao, Jonathan M Kurie, Lauren A Byers, Reza J Mehran, David C Rice, Luisa M Solis Soto

Dokumenty pełnotekstowe

Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA od Simon Heeke, PhD, Saumil Gandhi, MD, PhD, Hai T. Tran, PharmD, Vincent K. Lam, MD, Lauren A. Byers, MD, Don L. Gibbons, MD, PhD, Carl M. Gay, MD, PhD, Mehmet Altan, MD, Mara B. Antonoff, MD, FACS, Xiuning Le, MD, PhD, Janet Tu, MD, Maliazurina B. Saad, PhD, Michelle Pek, PhD, Jonathan Poh, PhD, Kao Chin Ngeow, DPhil, Anne Tsao, MD, MBA, FACHE, Tina Cascone, MD, PhD, Marcelo V. Negrao, MD, Jia Wu, PhD, George R. Blumenschein, Jr., MD, John V. Heymach, MD, PhD, Yasir Y. Elamin, MD

Dokumenty pełnotekstowe

Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC od Kaiwen Wang, PharmD, Robyn Du, BS, Sinchita Roy-Chowdhuri, MD, Ziping T. Li, MD, Lingzhi Hong, MD, Natalie Vokes, MD, Yasir Y. Elamin, MD, Celyne Bueno Hume, MD, Ferdinandos Skoulidis, MD, PhD, Carl M. Gay, MD, PhD, George Blumenschein, MD, Frank V. Fossella, MD, Anne Tsao, MD, Jianjun Zhang, MD, PhD, Niki Karachaliou, MD, Aurora O’Brate, PhD, Claudia-Nanette Gann, MD, Jeff Lewis, MS, Waree Rinsurongkawong, PhD, J. Jack Lee, PhD, MS, DDS, Don Lynn Gibbons, MD, PhD, Ara A. Vaporciyan, MD, John V. Heymach, MD, PhD, Mehmet Altan, MD, Xiuning Le, MD, PhD

Dokumenty pełnotekstowe

Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD od Byoung Chul Cho, MD, PhD, Makoto Nishio, MD, PhD, Myung-Ju Ahn, MD, PhD, Rosario García-Campelo, MD, Santiago Ponce, MD, Christina Baik, MD, MPH, Ravi Salgia, MD, PhD, Sang-We Kim, MD, PhD, Jong Seok Lee, MD, Tatsuya Yoshida, MD, PhD, Helena A. Yu, MD, Sarah B. Goldberg, MD, MPH, Adrianus Johannes de Langen, MD, PhD, Xiuning Le, MD, PhD, Zofia Piotrowska, MD, MHS, Jonathan W. Riess, MD, MS, Kentaro Tanaka, MD, PhD, Helen Ambrose, PhD, Jan Cosaert, MD, PhD, Paula G. Fraenkel, MD, Kwan Ho Tang, PhD, Jonathan M. Lehman, MD, PhD, Paul Smith, MSc, BSc, Jonathan W. Goldman, MD

Dokumenty pełnotekstowe